Universe Pharmaceuticals (UPC) Total Liabilities (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Total Liabilities of $15.8 million for Q1 2026, up 20.09% sequentially from $13.2 million in Q3 2025.
Universe Pharmaceuticals (UPC) Total Liabilities (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Total Liabilities for 7 years, with the latest figure at $15.8 million in Q1 2026.
- Quarterly Total Liabilities changed N/A year-over-year to $15.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (changed N/A YoY) and the FY2025 annual result came in at $13.2 million, down 99.94% from the prior year.
- Total Liabilities rose to $15.8 million in Q1 2026 per UPC's latest filing, from $13.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $22.5 billion in Q3 2024 and troughed at $13.2 million in Q3 2025.
- A 5-year average of $2.8 billion and a median of $41.1 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 163124.63% in 2024, then sank 99.94% in 2025.
- Over 5 years, Total Liabilities stood at $59.5 million in 2022, then sank by 76.9% to $13.8 million in 2023, then jumped by 163124.63% to $22.5 billion in 2024, then tumbled by 99.94% to $13.2 million in 2025, then grew by 20.09% to $15.8 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $15.8 million, $13.2 million, and $22.5 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | 15.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.82 Mn |
| Sep 30, 2025 | 13.17 Mn |
| Sep 30, 2024 | 22.45 Bn |
| Mar 31, 2024 | 22.69 Mn |
| Sep 30, 2023 | 13.75 Mn |
| Mar 31, 2023 | 70.37 Mn |
| Sep 30, 2022 | 59.54 Mn |
| Mar 31, 2022 | 71.37 Mn |
| Sep 30, 2021 | 70.14 Mn |
| Sep 30, 2020 | 28.80 |